Norges Bank
AXSM icon

Norges Bank’s Axsome Therapeutics AXSM Stock Holding History

Norges Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-495,456
Closed -$90.5M – 146
2025
Q4 		$90.5M Buy
+495,456
New +$69.2M 0.01% 797
2025
Q3 		– Sell
-468,329
Closed -$48.9M – 164
2025
Q2 		$48.9M Buy
468,329
+30,832
+7% +$3.26M 0.01% 960
2025
Q1 		$51M Buy
437,497
+34,471
+9% +$3.93M 0.01% 928
2024
Q4 		$34.1M Buy
403,026
+11,710
+3% +$1.08M ﹤0.01% 1109
2024
Q3 		$35.2M Sell
391,316
-12,901
-3% -$1.13M ﹤0.01% 1097
2024
Q2 		$32.5M Buy
404,217
+18,666
+5% +$1.38M ﹤0.01% 1081
2024
Q1 		$30.8M Buy
385,551
+190,428
+98% +$16M ﹤0.01% 1138
2023
Q4 		$15.5M Sell
195,123
-15,099
-7% -$1.01M ﹤0.01% 1341
2023
Q3 		$14.7M Hold
210,222
– – ﹤0.01% 1334
2023
Q2 		$15.1M Hold
210,222
– – ﹤0.01% 1379
2023
Q1 		$13M Sell
210,222
-46,175
-18% -$3.03M ﹤0.01% 1470
2022
Q4 		$19.8M Hold
256,397
– – ﹤0.01% 1275
2022
Q3 		$11.4M Buy
256,397
+23,351
+10% +$1.17M ﹤0.01% 1480
2022
Q2 		$8.93M Buy
233,046
+55,766
+31% +$1.76M ﹤0.01% 1606
2022
Q1 		$7.34M Sell
177,280
-15,049
-8% -$466K ﹤0.01% 1789
2021
Q4 		$7.27M Hold
192,329
– – ﹤0.01% 1841
2021
Q3 		$6.34M Buy
192,329
+130,106
+209% +$5.07M ﹤0.01% 1886
2021
Q2 		$4.2M Sell
62,223
-145,699
-70% -$8.74M ﹤0.01% 1930
2021
Q1 		$11.8M Sell
207,922
-66,987
-24% -$4.71M ﹤0.01% 1745
2020
Q4 		$22.4M Sell
274,909
-8,946
-3% -$669K 0.01% 1497
2020
Q3 		$20.2M Sell
283,855
-122,343
-30% -$9.53M 0.01% 1414
2020
Q2 		$33.4M Buy
406,198
+97,806
+32% +$7.53M 0.01% 1116
2020
Q1 		$18.1M Buy
+308,392
New +$25.1M 0.01% 1312

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank's AXSM Position: Q1 2026 in Review

Norges Bank sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 495,456 shares — an estimated $90.5M sold.

Norges Bank first reported a position in AXSM in Q1 2020 and held it in 23 quarters. The position peaked at $90.5M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Norges Bank reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 495,456 Axsome Therapeutics shares in Q1 2026, an estimated $90.5M.
  • Norges Bank first reported a position in Axsome Therapeutics in Q1 2020 and held it in 23 quarters.
  • Norges Bank's Axsome Therapeutics position peaked at $90.5M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.